IP Library › Assignment 047301/0786
Patent Assignment
Reel/Frame 047301/0786

Assignment of Assignor's Interest

Recorded: 2018-10-24 Pages: 83
Assignor
OREXIGEN THERAPEUTICS, INC.
Executed: 2018-07-27
Assignee
NALPROPION PHARMACEUTICALS, INC.
10 NORTH PARK PLACE, SUITE 201, MORRISTOWN, NEW JERSEY, 07960
Covered Property (1)
Methods of Treating Overweight and Obesity
Patent: 9,633,575 →
Application: 14/405,775 →
Publication: US 2015/0154883
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement Mar 21, 2016
From: OREXIGEN THERAPEUTICS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 038180/0021 →
Assignment of Assignor's Interest Mar 20, 2017
From: KLASSEN, PRESTON; TAYLOR, KRISTIN
To: OREXIGEN THERAPEUTICS, INC.
Reel/Frame 041648/0257 →
Security Interest Aug 6, 2018
From: NALPROPION PHARMACEUTICALS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 047288/0321 →
Release of Security Interest Sep 27, 2019
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 050574/0106 →
Change of Name Oct 17, 2019
From: NALPROPION PHARMACEUTICALS, INC.
To: NALPROPION PHARMACEUTICALS LLC
Reel/Frame 050750/0497 →
Security Interest Dec 19, 2019
From: CURRAX PHARMACEUTICALS LLC; NALPROPION PHARMACEUTICALS LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 051377/0958 →